Charities and patients welcome NICE decision to reconsider the removal of a “lifeline” cell therapy from the NHS
Stem cell charity Anthony Nolan, together with Blood Cancer UK and Lymphoma Action, welcome the decision by NICE to reconsider the removal of the CAR T-cell therapy Tecartus (brexucabtagene autoleucel) as a treatment for mantle cell lymphoma. After five years of Tecartus being available on the NHS in England […]
Lymphoma Study Day
Join us on Tuesday 28th April 2025 for the Lymphoma Hybrid Study Day. A hybrid study day for Nurses/ACP’s and AHP’s involved in the care of patients with lymphoma, aiming […]
First global patient recruited to new cancer treatment study
A grandfather from Folkestone is the first in the world to be recruited to a study trialling a new treatment for patients who have suffered a relapse of lymphoma, a […]
Possible association between tattoos and lymphoma revealed
A new study from Lund University in Sweden suggests that tattoos could be a risk factor for cancer in the lymphatic system – prompting researchers to underline the need for […]
Virtual Lymphoma Management Course 2023
The Lymphoma Management Course is delivered virtually, and comprises of four weekly sessions, covering many key topics essential for the effective management of lymphomas. The content is suitable for healthcare professionals […]
FDA issues safety alert that breast implants have been linked to additional cancers
The US Food and Drug Administration has issued a safety communication about reports of squamous cell carcinoma (SCC) and various lymphomas located in the capsule or scar tissue around breast implants. After […]
